1-9 of 9
Juan-José Lahuerta, MD
Close
Sort by
Journal Articles

Long Term Significance of Response in Multiple Myeloma After Stem Cell Transplantation.

Joaquin Martínez-López, Joan Blade, M. Carmen Gomez del Castillo, Maria Victoria Mateos, Adrian Alegre, MD, José Garcia-Laraña, Anna Sureda, Javier de la Rubia, Eulogio Conde, MD, Rafael Martínez, Felipe de Arriba, Jose Luis Gomez Zamudio, Juan Besalduch, Rafael Cabrera, M. Cruz Biguria, Jose Maria Moraleda, J.F San Miguel, Juan José Lahuerta, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1811.
https://doi.org/10.1182/blood.V114.22.1811.1811
Published: 2009
Journal Articles

Impact of FISH and Cytogenetics On Overall and Event Free Survival in Myeloma: An IMWG Analysis of 9,897 Patients.

Herve Avet-Loiseau, Brian G M Durie, Jeff Haessler, MD, John Crowley, PhD, Antje Hoering, Ph.D., Bart Barlogie, MD, PhD, John D Shaughnessy, Jr., Orhan Sezer, Chaim Shustik, MD, Roman Hajek, MD, Harmut Goldschmidt, Pieter Sonneveld, Philippe Moreau, MD, Michel Attal, MD, Antonio Palumbo, M.D., Mario Boccadoro, MD, Jae Hoon Lee, Jan Westin, MD, PhD, Ingemar Turesson, MD, PhD, Jesús F. San Miguel, Joan Blade, Juan José Lahuerta, MD, PhD, Santiago Pavlovsky, MD, PhD, Dorotea Beatriz Fantl, MD, S.Vincent Rajkumar, M.D., Rafael Fonseca, MD
Journal: Blood
Blood (2009) 114 (22): 743.
https://doi.org/10.1182/blood.V114.22.743.743
Published: 2009
Journal Articles

A Prospective, Multicenter, Randomized, Trial of Bortezomib/Melphalan/Prednisone (VMP) Versus Bortezomib/Thalidomide/Prednisone (VTP) as Induction Therapy Followed by Maintenance Treatment with Bortezomib/Thalidomide (VT) Versus Bortezomib/Prednisone (VP) in Elderly Untreated Patients with Multiple Myeloma Older Than 65 Years.

Maria-Victoria Mateos, MD, PhD, Albert Oriol, MD, Joaquin Martinez, MD, M Teresa Cibeira, Norma C. Gutiérrez, Maria Jose Terol, MD, Raquel de Paz, MD, PhD, Jose García-Laraña, Enrique Bengoechea, Alejandro Martín García-Sancho, Rafael Martínez, Luis Palomera, Felipe de Arriba, Yolanda Gonzalez, José Hernández, Anna Sureda, MD, PhD, Jose-Luis Bello, Juan José Lahuerta, MD, PhD, Joan Blade, M.D., Jesús F. San-Miguel, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3.
https://doi.org/10.1182/blood.V114.22.3.3
Published: 2009
Journal Articles

Natural History of Multiple Myeloma Relapsing After Therapy with IMiDs and Bortezomib: A Multicenter International Myeloma Working Group Study.

Shaji Kumar, Joan Blade, M.D., John Crowley, PhD, Harmut Goldschmidt, Antje Hoering, Ph.D., Sundar Jagannath, MD, Juan José Lahuerta, MD, PhD, Jacob Laubach, Philippe Moreau, MD, Gareth Morgan, Robert Z. Orlowski, Antonio Palumbo, M.D., Paul Richardson, M.D., Ph.D., Jesús F. San Miguel, Orhan Sezer, David Siegel, Pieter Sonneveld, Jackie Szymonifka, S.Vincent Rajkumar, M.D., Brian G M Durie
Journal: Blood
Blood (2009) 114 (22): 2878.
https://doi.org/10.1182/blood.V114.22.2878.2878
Published: 2009
Journal Articles

A Phase I/II, National, Multicenter, Open Label Study of Bortezomib (Velcade) and Fludarabine, Cytarabine and Idarubicin (Flag-Ida) (V-Flag-Ida) in Pts with Relapsed and/or Refractory Acute Myeloblastic Leukemia (AML).

Maria-Victoria Mateos, Rafael Martínez, Salut Brunet, Maria-Belén Vidriales, Albert Oriol, MD, Juan José Lahuerta, MD, PhD, Mari Luz Amigo, Jordi Esteve, Javier de la Rubia, Luis Palomera, Javier Bueno, Jesus F San Miguel
Journal: Blood
Blood (2009) 114 (22): 4140.
https://doi.org/10.1182/blood.V114.22.4140.4140
Published: 2009
Journal Articles

Multicenter, Randomized, Open-Label, Phase III Trial of Lenalidomide-Dexamethasone (Len/dex) Vs Therapeutic Abstention in Smoldering Multiple Myeloma at High Risk of Progression to Symptomatic MM: Results of the First Interim Analysis.

Maria-Victoria Mateos, MD, PhD, Lucía López-Corral, Miguel T Hernández, Javier de la Rubia, Juan José Lahuerta, MD, PhD, Pilar Giraldo, MD, Joan Bargay, MD, Laura Rosiñol, Albert Oriol, MD, Jose García-Laraña, Luis Palomera, Felipe de Arriba, Felipe Prosper, MD, Mariluz Martino, MD, Ana-Isabel Teruel, José Hernández, Graça Esteves, Mario Mariz, Adrian Alegre, MD, J.L. Guzmán, Nuria Quintana, Jose-Luis Garcia, Jesús F. San-Miguel, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 614.
https://doi.org/10.1182/blood.V114.22.614.614
Published: 2009
Journal Articles

Final Results of a Phase II Trial with Plitidepsin (Aplidin) Alone and in Combination with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Maria-Victoria Mateos, Mª Teresa Cibeira, Paul Richardson, Joan Blade, Felipe Prosper, MD, Albert Oriol, Javier de la Rubia, MD, Adrian Alegre, MD, Juan José Lahuerta, MD, PhD, Ramón García-Sanz, MD, PhD, Constantine S. Mitsiades, MD, PhD, Jose Espinoza, MD, Kenneth C. Anderson, J.F. San Miguel
Journal: Blood
Blood (2008) 112 (11): 3700.
https://doi.org/10.1182/blood.V112.11.3700.3700
Published: 2008
Journal Articles

VAMP/ThaCyDex: Velcade® (Bortezomib), Adriamycin, Melphalan and Prednisone Alternating with Thalidomide, Cyclophosphamide and Dexametasone as a Salvage Regimen in Relapsed Multiple Myeloma Patients

Enrique Colado, MD, Maria-Victoria Mateos, MD, PhD, Maria-Jose Moreno, MD, Felipe de Arriba, MD, Javier de la Rubia, MD, Juan José Lahuerta, MD, PhD, Pastora Iniesta, MD, Maria Cruz Viguria, MD, Ana Pilar Gonzalez, MD, Ramón García-Sanz, MD, PhD, Juan Olazabal, MD, Jesús F San Miguel
Journal: Blood
Blood (2008) 112 (11): 3694.
https://doi.org/10.1182/blood.V112.11.3694.3694
Published: 2008
Journal Articles

Anti-Thymocyte Globulin Induces Higher Response Rates and Less Graft-Versus-Host Disease in Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplantation.

Francis Ayuk, MD, José A. Perez-Simon, MD, Avichai Shimoni, MD, Anna Sureda, MD, Tatjana Zabelina, MD, Rainer Schwerdtfeger, MD, Rodrigo Martino, MD, Herbert G. Sayer, MD, Adrián Alegre, MD, Juan-José Lahuerta, MD, Djordje Atanackovic, MD, Christine Wolschke, MD, Arnon Nagler, MD, Axel R. Zander, MD, Jesús San Miguel, MD, Nicolaus Kroeger, MD
Journal: Blood
Blood (2007) 110 (11): 2980.
https://doi.org/10.1182/blood.V110.11.2980.2980
Published: 2007